Literature DB >> 12409270

Association of the acid phosphatase (ACP1) gene with triglyceride levels in obese women.

Nunzio Bottini1, James MacMurray, Warren Peters, Masoud Rostamkhani, David E Comings.   

Abstract

The acid phosphatase (ACP1) locus codes for a low molecular weight protein tyrosine phosphatase (LMPTP) that is found ubiquitously in human tissues. The *A allele of the ACP1 gene is associated with lower total enzymatic activity than the *B and *C alleles. An association between the *A allele and extreme values of body-mass-index (BMI) and dyslipidemia has previously been described in several samples of obese subjects from the Italian population. In the present study, we investigated the relationship between ACP1 *A allele genotypes (*A/*A, *A/*B, and *A/*C) and non-*A allele genotypes (*B/*B, *B/*C, and *C/*C) and metabolic variables in 277 Caucasian post-menopausal subjects consisting of 82 non-obese subjects (BMI</=29), 60 moderately obese (BMI 30-34) and 135 very obese (BMI>/=35) subjects. ACP1 genotypes were found to be significantly associated with total cholesterol (p</=0.002) and triglyceride (p</=0.001) levels in the obese and very obese women only. The significantly lower levels of triglycerides in *A carriers in this group suggest a protective effect of the *A allele against hypertriglyceridemia. It has been unclear why some individuals who gain weight develop dyslipidemia and other aspects of the metabolic syndrome while others do not. The present study suggests that those who gain weight and carry the ACP1 *A allele may be partially protected against developing the metabolic syndrome. The confirmation of ACP1 as a modifier gene of the metabolic complications could open the door to the prevention of the lethal complications of obesity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12409270     DOI: 10.1016/s1096-7192(02)00120-8

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  14 in total

Review 1.  Role of genetic susceptibility in development of treatment-related adverse outcomes in cancer survivors.

Authors:  Smita Bhatia
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-10       Impact factor: 4.254

2.  Genes identified through genome-wide association studies of osteonecrosis in childhood acute lymphoblastic leukemia patients.

Authors:  Vincent Gagné; Anne Aubry-Morin; Maria Plesa; Rachid Abaji; Kateryna Petrykey; Pascal St-Onge; Patrick Beaulieu; Caroline Laverdière; Nathalie Alos; Jean-Marie Leclerc; Stephen E Sallan; Donna Neuberg; Jeffery L Kutok; Lewis B Silverman; Daniel Sinnett; Maja Krajinovic
Journal:  Pharmacogenomics       Date:  2019-11-05       Impact factor: 2.533

3.  Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia.

Authors:  Jitesh D Kawedia; Sue C Kaste; Deqing Pei; John C Panetta; Xiangjun Cai; Cheng Cheng; Geoffrey Neale; Scott C Howard; William E Evans; Ching-Hon Pui; Mary V Relling
Journal:  Blood       Date:  2010-12-10       Impact factor: 22.113

4.  Evidence for sex-specific associations between variation in acid phosphatase locus 1 (ACP1) and insulin sensitivity in Mexican-Americans.

Authors:  Yu-Hsiang Shu; Jaana Hartiala; Anny H Xiang; Enrique Trigo; Jean M Lawrence; Hooman Allayee; Thomas A Buchanan; Nunzio Bottini; Richard M Watanabe
Journal:  J Clin Endocrinol Metab       Date:  2009-07-21       Impact factor: 5.958

Review 5.  Low molecular weight protein tyrosine phosphatase as signaling hub of cancer hallmarks.

Authors:  Alessandra V S Faria; Emanuella Maria Barreto Fonseca; Helon Guimarães Cordeiro; Stefano Piatto Clerici; Carmen Veríssima Ferreira-Halder
Journal:  Cell Mol Life Sci       Date:  2020-10-14       Impact factor: 9.261

Review 6.  Protein tyrosine phosphatases as potential therapeutic targets.

Authors:  Rong-Jun He; Zhi-Hong Yu; Ruo-Yu Zhang; Zhong-Yin Zhang
Journal:  Acta Pharmacol Sin       Date:  2014-09-15       Impact factor: 6.150

7.  Association of HS6ST3 gene polymorphisms with obesity and triglycerides: gene x gender interaction.

Authors:  Ke-Sheng Wang; Liang Wang; Xuefeng Liu; Min Zeng
Journal:  J Genet       Date:  2013-12       Impact factor: 1.166

8.  Association of acid phosphatase locus 1*C allele with the risk of cardiovascular events in rheumatoid arthritis patients.

Authors:  María Teruel; Jose-Ezequiel Martin; Carlos González-Juanatey; Raquel López-Mejias; Jose A Miranda-Filloy; Ricardo Blanco; Alejandro Balsa; Dora Pascual-Salcedo; Luis Rodriguez-Rodriguez; Benjamin Fernández-Gutierrez; Ana M Ortiz; Isidoro González-Alvaro; Carmen Gómez-Vaquero; Nunzio Bottini; Javier Llorca; Miguel A González-Gay; Javier Martin
Journal:  Arthritis Res Ther       Date:  2011-07-18       Impact factor: 5.156

9.  Diabetes reversal by inhibition of the low-molecular-weight tyrosine phosphatase.

Authors:  Stephanie M Stanford; Alexander E Aleshin; Vida Zhang; Robert J Ardecky; Michael P Hedrick; Jiwen Zou; Santhi R Ganji; Matthew R Bliss; Fusayo Yamamoto; Andrey A Bobkov; Janna Kiselar; Yingge Liu; Gregory W Cadwell; Shilpi Khare; Jinghua Yu; Antonio Barquilla; Thomas D Y Chung; Tomas Mustelin; Simon Schenk; Laurie A Bankston; Robert C Liddington; Anthony B Pinkerton; Nunzio Bottini
Journal:  Nat Chem Biol       Date:  2017-03-27       Impact factor: 15.040

10.  The low molecular weight protein tyrosine phosphatase promotes adipogenesis and subcutaneous adipocyte hypertrophy.

Authors:  Stephanie M Stanford; Meghan Collins; Michael A Diaz; Zachary J Holmes; Paul Gries; Matthew R Bliss; Alessia Lodi; Vida Zhang; Stefano Tiziani; Nunzio Bottini
Journal:  J Cell Physiol       Date:  2021-02-21       Impact factor: 6.513

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.